{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:57Z","timestamp":1761519057577,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.4158\/ep.13.4.417","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:55:21Z","timestamp":1365198921000},"page":"417-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Octreotide Therapy for Recurrent Refractory Hypoglycemia Due to Sulfonylurea In Diabetes-Related Kidney Failure"],"prefix":"10.1016","volume":"13","author":[{"given":"Rita R.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Zweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romy","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren W.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"FACE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.13.4.417_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8529(18)30395-5","article-title":"Drug-induced hypoglycemia: a review of 1418 cases","volume":"18","author":"Seltzer","year":"1989","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.13.4.417_bb0010","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"1701","article-title":"Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas","author":"Davis","year":"2001"},{"key":"10.4158\/EP.13.4.417_bb0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0272-6386(00)70204-6","article-title":"Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease","volume":"35","author":"Krepinsky","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP.13.4.417_bb0020","first-page":"95","article-title":"Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia","volume":"14","author":"Graudins","year":"1996","journal-title":"Am J Emerg Med."},{"key":"10.4158\/EP.13.4.417_bb0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/diacare.16.1.184","article-title":"Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide","volume":"1","author":"Krentz","year":"1993","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5694\/j.1326-5377.2004.tb06064.x","article-title":"Octreotide treatment for sul-fonylurea-induced hypoglycemia","volume":"180","author":"Crawford","year":"2004","journal-title":"Med J Aust."},{"key":"10.4158\/EP.13.4.417_bb0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/039139880302600113","article-title":"Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure","volume":"26","author":"Nzerue","year":"2003","journal-title":"Int J Artif Organs."},{"key":"10.4158\/EP.13.4.417_bb0040","first-page":"189","article-title":"Octreotide for the treatment of sulfony-lurea induced hypoglycaemia in type 2 diabetes","volume":"110","author":"Braatvedt","year":"1997","journal-title":"N Z Med J."},{"key":"10.4158\/EP.13.4.417_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mem.2000.108183","article-title":"Octreotide: an antidote for sulfonylurea-induced hypoglycemia","volume":"36","author":"McLaughlin","year":"2000","journal-title":"Ann Emerg Med."},{"key":"10.4158\/EP.13.4.417_bb0050","first-page":"752","article-title":"Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses","volume":"76","author":"Boyle","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.417_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0736-4679(03)00204-X","article-title":"Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia","volume":"25","author":"Green","year":"2003","journal-title":"J Emerg Med."},{"key":"10.4158\/EP.13.4.417_bb0060","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1081\/JDI-100100866","article-title":"Hypoglycemia in patients with renal failure","volume":"22","author":"Haviv","year":"2000","journal-title":"Ren Fail."},{"key":"10.4158\/EP.13.4.417_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0889-8529(18)30391-8","article-title":"Hypoglycemia associated with renal failure","volume":"18","author":"Arem","year":"1989","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.13.4.417_bb0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.24.2.382","article-title":"Renal gluconeogenesis: its importance in human glucose homeostasis","volume":"24","author":"Gerich","year":"2001","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0080","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diabetes.51.3.724","article-title":"Hypoglycemia-associated autonomic failure in advanced type 2 diabetes","volume":"51","author":"Segel","year":"2002","journal-title":"Diabetes."},{"key":"10.4158\/EP.13.4.417_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/diacare.25.1.107","article-title":"The sulfonylurea glyburide induces impairment of glucagon and growth hormone responses during mild insulin-induced hypoglycemia","volume":"25","author":"ter Braak","year":"2002","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0090","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2337\/diacare.26.6.1852","article-title":"Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001","volume":"26","author":"Wysowski","year":"2003","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0095","series-title":"Williams Textbook of Endocrinology","first-page":"1427","article-title":"Type 2 diabetes mellitus","author":"Buse","year":"2003"},{"key":"10.4158\/EP.13.4.417_bb0100","first-page":"1231","article-title":"Oral hypoglycemic agents [erratum in N Engl J Med. 1990;322:71]","volume":"321","author":"Gerich","year":"1989","journal-title":"N Engl J Med."},{"issue":"Suppl 3","key":"10.4158\/EP.13.4.417_bb0105","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.2337\/diabetes.51.2007.S368","article-title":"Sulfonylurea stimulation of insulin secretion","volume":"51","author":"Proks","year":"2002","journal-title":"Diabetes."},{"key":"10.4158\/EP.13.4.417_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006565-199906000-00015","article-title":"Management of sulfonylurea ingestions","volume":"15","author":"Spiller","year":"1999","journal-title":"Pediatr Emerg Care."},{"key":"10.4158\/EP.13.4.417_bb0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1067\/mem.2001.114314","article-title":"Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment","volume":"38","author":"Harrigan","year":"2001","journal-title":"Ann Emerg Med."},{"key":"10.4158\/EP.13.4.417_bb0120","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.17.9.1026","article-title":"Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans","volume":"17","author":"Rydberg","year":"1994","journal-title":"Diabetes Care."},{"key":"10.4158\/EP.13.4.417_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-201X.1996.32261000.x","article-title":"Glucagon, glucagon-like peptide-1 and their receptors: an introduction","volume":"157","author":"Holst","year":"1996","journal-title":"Acta Physiol Scand."},{"key":"10.4158\/EP.13.4.417_bb0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0026-0495(72)90030-3","article-title":"Factors affecting insulin response to glucagon in man","volume":"21","author":"Oakley","year":"1972","journal-title":"Metabolism."},{"key":"10.4158\/EP.13.4.417_bb0135","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archinte.1991.00400090133023","article-title":"Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy","volume":"151","author":"Palatnick","year":"1991","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.13.4.417_bb0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.13.4.417_bb0145","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1210\/endo.140.8.6937","article-title":"Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells","volume":"140","author":"Mitra","year":"1999","journal-title":"Endocrinology."},{"key":"10.4158\/EP.13.4.417_bb0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4065\/80.4.502","article-title":"Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors","volume":"80","author":"Delaunoit","year":"2005","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP.13.4.417_bb0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1994.2670","article-title":"Specific inhibition of rat pan creatic insulin or glucagon release by receptor-selective somatostatin analogs","volume":"205","author":"Rossowski","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"10.4158\/EP.13.4.417_bb0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front Neuroendocrinol."},{"key":"10.4158\/EP.13.4.417_bb0165","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jcem-60-6-1161","article-title":"The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients","volume":"60","author":"Lamberts","year":"1985","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.13.4.417_bb0170","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/00006676-200311000-00019","article-title":"Activation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas","volume":"27","author":"Brunicardi","year":"2003","journal-title":"Pancreas."},{"key":"10.4158\/EP.13.4.417_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000181005","article-title":"The use of SMS 201-995 (somatostatin analogue) in insulinomas: additional case report and literature review","volume":"29","author":"Hearn","year":"1988","journal-title":"Horm Res."},{"key":"10.4158\/EP.13.4.417_bb0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1179\/joc.2003.15.1.85","article-title":"Severe and prolonged hypoglycemia triggered by long-acting octreotide in a patient with malignant mesenchymal tumor: case report","volume":"15","author":"Sari","year":"2003","journal-title":"J Chemother."},{"key":"10.4158\/EP.13.4.417_bb0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/cc3807","article-title":"Bench-to bedside review: antidotal treatment of sulfonylurea-induced hypoglycemia with octreotide","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20418622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/M4332861VT1725G3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:47:22Z","timestamp":1761515242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20418622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1530891X20418622"],"URL":"https:\/\/doi.org\/10.4158\/ep.13.4.417","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Octreotide Therapy for Recurrent Refractory Hypoglycemia Due to Sulfonylurea In Diabetes-Related Kidney Failure","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.13.4.417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}